Skip to content
Surprising Science

The Age of Live Stem-Cell Therapy

After years of controversy, a therapy based on human embryonic stem cells is finally being tested in humans. The treatment holds out hope to paralyzed people, but at how great a risk?
Sign up for Big Think on Substack
The most surprising and impactful new stories delivered to your inbox every week, for free.

What’s the Latest Development?


When Hans Keirstead, a biologist at the University of California, Irvine, rehabilitated paralyzed rats by injecting stem-cells into their spines, the medical world marveled at what the future might hold. Thirteen years later, a private biotechnology firm, after leasing Keirstead’s medical patents, has made stem-cell treatments for paraplegics the core of its research. The F.D.A. has approved stem-cell treatment for spinal cord injuries in humans, albeit with a series of safety precautions. Still, some in the medical community say there is not yet enough research to justify testing on humans. 

What’s the Big Idea?

The road to stem-cell therapy has been a difficult one yet the technology remains truly revolutionary. Stem-cells are unique in that they can grow to become the tissue of any organ in the body. This has been a blessing and a curse for medical researchers. When injected with stem-cells, some damaged tissue has indeed recovered, but sometimes the stem-cells did not forget their original duty, to create an entire person. This has led to the development of tumors called teratomas that are composed of multi-organ tissues like teeth, bone and hair. 

Sign up for Big Think on Substack
The most surprising and impactful new stories delivered to your inbox every week, for free.

Related

Up Next